Almouneer, the digital transformation platform revolutionising healthcare for patients and doctors across the Middle East and Africa (MEA), has secured a US$3.6 million seed round f
The seed round was led by Dubai-based Global Ventures, with participation from other renowned international investors including Proparco and Digital Africa, through the Bridge Fund, Wrightwood Investments – the family office of Diane & Henry Engelhardt (UK) – and other leading international funds.
Noha Khater, co-founder and CEO of Almouneer, said: “We are very excited to be announcing this round—an important achievement and milestone in our journey. Over the past year, we managed to grow our team and successfully build DRU. This round will now catapult us into the next phase of our business, helping us grow our team and talent further, invest in our technology, and broaden DRU’s provider network—inching us even closer to our vision. And as we do, we’d like to extend our deepest gratitude to our investors—Noor Sweid and Said Murad from Global Ventures, Henry Engelhardt of Wrightwood Investments, and Proparco—for their belief in us and in our mission. We also wouldn’t be here today had it not been for the unwavering support and championing of Cartier Women’s Initiative, INSEAD, Endeavor and our friends at Alliance Law Firm.”
The fundraise follows rapid growth for Almouneer as it serves over 120,000 patients, with business volumes having doubled in the last year and its leadership team boosted with several key hires.
The investment is aimed to support the development and expansion of DRU – MEA’s first patient-centric, digitally-enabled lifestyle and diabetes management platform. DRU aids in the prevention and management of diabetes, pre-diabetes, and obesity – and will serve millions in Egypt and MEA. The scalable platform uses cutting-edge patient and doctor-facing applications and an extensive provider network.
Proceeds will enhance DRU’s state-of-the-art technology further and grow its wider provider ecosystem (doctors / health coaches / labs / nutritionists). Almouneer will also build MEA’s first online, patient-customized treatment plans. DRU currently connects to Continuous Glucose Monitors and other glucometers and will soon enable connection to wearables such as smart watches.
The company is planning to launch its DRU app for doctors – connecting healthcare providers with millions of patients. The company’s strategy is to expand regionally and internationally – with market entries to Saudi Arabia, the U.A.E., and African countries including Nigeria and Kenya – anticipated by next year.
The MEA region has very high levels of obesity and prediabetes – affecting over 40% of its population – making Almouneer and DRU’s mission to empower patients and healthcare professionals more critical than ever.
Noor Sweid, Founder and Managing Partner of Global Ventures, commented: “We are thrilled to welcome Almouneer to the Global Ventures portfolio and lead the company’s seed round. Over the years, we have had the privilege of working with a stellar group of healthcare entrepreneurs who are materially improving the lives of patients worldwide, enhancing access, quality and cost of care. Noha and Rania are now part of this group. We are excited to work alongside them as they leverage their specialized expertise across business-building and chronic care to tackle a prevalent health issue across the Middle East and Africa. On its mission to become the lifelong companion of diabetic patients in the region, Almouneer is a unique and necessary innovation.”
